DYNE THERAPEUTICS INC's ticker is DYN and the CUSIP is 26818M108. A total of 1 filers reported holding DYNE THERAPEUTICS INC in Q4 2023. The put-call ratio across all filers is - and the average weighting 32.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $71,000 | +24.6% | 8,010 | +57.7% | 0.00% | – |
| Q2 2023 | $57,000 | +72.7% | 5,078 | +72.8% | 0.00% | – |
| Q1 2023 | $33,000 | -40.0% | 2,938 | -37.9% | 0.00% | – |
| Q4 2022 | $55,000 | +175.0% | 4,734 | +205.6% | 0.00% | – |
| Q3 2022 | $20,000 | +122.2% | 1,549 | +15.5% | 0.00% | – |
| Q2 2022 | $9,000 | -69.0% | 1,341 | -55.4% | 0.00% | – |
| Q1 2022 | $29,000 | -67.0% | 3,009 | -59.5% | 0.00% | – |
| Q4 2021 | $88,000 | +8.6% | 7,438 | +50.4% | 0.00% | – |
| Q3 2021 | $81,000 | +88.4% | 4,946 | +140.1% | 0.00% | – |
| Q2 2021 | $43,000 | +79.2% | 2,060 | +33.6% | 0.00% | – |
| Q1 2021 | $24,000 | +71.4% | 1,542 | +135.1% | 0.00% | – |
| Q4 2020 | $14,000 | – | 656 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Vida Ventures Advisors, LLC | 2,220,034 | $19,891,505 | 30.79% |
| MPM ASSET MANAGEMENT LLC | 4,951,303 | $44,363,675 | 23.76% |
| Atlas Venture Life Science Advisors, LLC | 9,885,449 | $88,573,623 | 13.72% |
| Logos Global Management LP | 2,180,000 | $19,532,800 | 2.61% |
| TCG Crossover Management, LLC | 1,650,150 | $14,785,344 | 2.18% |
| VR Adviser, LLC | 2,173,913 | $19,478,260 | 2.05% |
| Altium Capital Management LP | 315,000 | $2,822,400 | 1.47% |
| Vivo Capital, LLC | 1,035,136 | $9,274,819 | 1.02% |
| Octagon Capital Advisors LP | 692,945 | $6,208,787 | 0.95% |
| ACUTA CAPITAL PARTNERS, LLC | 146,500 | $1,312,640 | 0.88% |